Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Gang Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6801-0294; OpenAlex author ID A5101880977. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 3 papers · 2021: none · 2022: 1 paper

Papers 9

  1. Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells. Co-author DOI 10.3892/ol.2022.13227↗
  2. Magnolol Suppresses Pancreatic Cancer Development In Vivo and In Vitro via Negatively Regulating TGF-β/Smad Signaling. Last author DOI 10.3389/fonc.2020.597672↗
  3. MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1. Co-author DOI 10.7150/ijbs.45933↗
  4. The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer. Co-author DOI 10.7150/jca.40953↗
  5. Upregulation of LASP2 inhibits pancreatic cancer cell migration and invasion through suppressing TGF-β-induced EMT. Co-author DOI 10.1002/jcb.28638↗
  6. High expression of microRNA-4295 contributes to cell proliferation and invasion of pancreatic ductal adenocarcinoma by the down-regulation of Glypican-5. Co-author DOI 10.1016/j.bbrc.2018.02.023↗
  7. Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells. Co-author DOI 10.3892/ol.2018.8219↗
  8. Early manifestations of pancreatic cancer: the effect of cancer-nerve interaction. Co-author DOI 10.1016/j.mehy.2013.05.010↗
  9. The bidirectional interation between pancreatic cancer and diabetes. First author DOI 10.1186/1477-7819-10-171↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenbin Yang · 4 shared papers, 2018–2022 · strength 0.45
  2. Tao Shan · 4 shared papers, 2018–2022 · strength 0.43
  3. Junhui Li · 3 shared papers, 2018–2020 · strength 0.34
  4. Shuo Chen · 3 shared papers, 2020 · strength 0.34
  5. Qinggong Yuan · 2 shared papers, 2018–2019 · strength 0.23
  6. Shuo Chen · 2 shared papers, 2018–2022 · strength 0.21
  7. Ya’an Kang · 2 shared papers, 2018–2022 · strength 0.21
  8. Jiaqi Shen · 2 shared papers, 2020 · strength 0.21
  9. Li Zhang · 2 shared papers, 2013–2020 · strength 0.17
  10. Wunai Zhang · 1 shared paper, 2020 · strength 0.13
  11. Wen‐Bin Yang · 1 shared paper, 2019 · strength 0.12
  12. Yan Zhang · 1 shared paper, 2019 · strength 0.12
  13. Yang Liu · 1 shared paper, 2020 · strength 0.11
  14. Qingyong Ma · 2 shared papers, 2012–2013 · strength 0.08
  15. Wei Li · 1 shared paper, 2018 · strength 0.07
  16. Xi Chen · 1 shared paper, 2018 · strength 0.07
  17. Li Wang · 1 shared paper, 2018 · strength 0.07
  18. Junhui Li · 1 shared paper, 2013 · strength 0.04
  19. Junhui Li · 1 shared paper, 2012 · strength 0.04
  20. Wei Li · 1 shared paper, 2012 · strength 0.04
  21. Han Liu · 1 shared paper, 2012 · strength 0.04
  22. Liang Han · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.